Furthermore, in APP/PS1 mice, a widely used AD mouse model, MT2 protein and mRNA expression levels were dramatically reduced in the hippocampus beginning at 7 months of age (Figure 1f–i), at which point dendritic abnormalities were also found (Figure 1f). This evidence concerns the gene APP and Alzheimer disease.